Plasma-derived therapies

These companies make medicines like immune globulin and clotting factors from donated human plasma.
−16.9%
over 1 year · S&P 500 +11.6%

Key indicators

Health
60 / 100
Fragile
Solid
Price
P/E 17
Cheap
Expensive
Up over 1 year
2 of 3
Volatility
32%
Calm
Choppy
Health and price: against the other tags.

The 3 companies

ADMA
−16.9%
Size: weight in the tag. Color: move over the period.
See all companies
A
ADMA Biologics
ADMA
100%
−16.9%
G
Grifols
GRFS
+1.2%
T
Takeda Pharmaceutical
TAK
+54.2%